Low-dose CT scan 4-times more likely to detect malignant mass than x-ray

While traditional screenings for lung cancer include chest x-rays and sputum cytology, a low-dose computed tomography (CT) scan is the latest technology to identify small cancer growths before symptoms develop.

Scott Pierce, MD, who works at KentuckyOne Health Hematology and Oncology, notes this new screening is four times more likely to find a malignant mass than a traditional x-ray, leading to earlier detection and an increased rates of survival.

Read the full article: 

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.